INTRODUCTION
Cardiovascular morbidity and mortality is increased in patients with obstructive sleep apnoea (OSA), an independent risk factor for hypertension and left ventricular diastolic dysfunction [1] [2] [3] [4] . Population studies estimate that 2 and 4% of middle age women and men respectively, have OSA [5] . Postulated mechanisms linking chronic intermittent hypoxia and arousals in OSA with cardiovascular disease include transient episodes of hypertension, endothelial dysfunction and increased arterial stiffness, elevated sympathetic activity, intrathoracic pressures changes, inflammation and oxidative stress [6] [7] [8] [9] [10] [11] .
Oxidative stress is characterized by an imbalance between oxidant-producing systems and antioxidant defence mechanisms, resulting in excessive formation of reactive oxygen species (ROS), chemically reactive by products of oxygen metabolism. At lower levels, ROS participate in physiologic signalling pathways [12] .
Detrimental modification of cell structures encompassing membranes, proteins, lipids and DNA, can occur when higher levels of ROS or reactive nitrogen species (RNS) are present. Oxidative modification of low-density lipoproteins (LDL) in the arterial wall is a key feature of atherogenesis [13] . A recently published population based study demonstrated an independent association between 10-year CAD events and plasma, oxidisable LDL level in a general population (Gomez et al, 2013 -not on pubmed yet). In OSA, the presence of increased oxidant molecules is further accompanied by reduced antioxidant capacity in OSA [14, 15] .
Several randomized controlled trials in OSA have investigated the impact of continuous positive airway pressure (CPAP) on various oxidative markers. Lipid peroxidation markers utilized range from 8-isoprostane concentrations in plasma, urine and exhaled breath condensate as a reflection of airway lining fluid composition [16] [17] [18] , to determination of malondialdehyde (MDA) in the thiobarbituric acid-reactive substance (TBARS) test, as an indirect method of assessment of lipid peroxidation [13, 19, 20] . Other oxidative markers measured include total levels of hydroperoxides [21] and nitrotyrosine, by product of tyrosine nitration mediated by RNS [22] . In addition, antioxidant protective enzyme paraxonase-1 (PON1) [13, 19, 20] , total antioxidant, vitamin A, E and gamma-glutamyltransferase levels (GGT) [23] have also been assessed as measures of antioxidant capacity in OSA. Most studies have shown a reduction in oxidative markers with CPAP.
In a previously published study, improvements in postprandial triglycerides and total cholesterol were demonstrated with 8 weeks of CPAP use [24] . Here, we investigate the effect of CPAP on directly measured lipid markers of oxidative damage and plasma lipophilic anti-oxidant levels before and after sleep.
METHODS

Participants
The protocol has previously been reported in a study which assessed the effect of CPAP treatment on postprandial lipidemia [24] . Details of randomization, allocation concealment and blinding and the flow of patients through the trial are included in the original report. Briefly, we recruited patients from sleep apnoea clinics who were [25] .
Study design
Patients who met the inclusion/exclusion criteria were randomized to receive CPAP (Remstar Auto, Phillips Respironics, USA) or sham CPAP each for 8 weeks in a crossover design with an intervening 1 month washout period between treatments ( Figure 1 ). Sham CPAP devices are identical in appearance to the therapeutic devices except that the pressure delivered at the mask remains at 0.5 cmH2O, having no effect on sleep disordered breathing. In contrast, therapeutic CPAP was set to a pressure which prevented most sleep disordered breathing. This was determined during an at home pressure determination study as previously described [24] . Compliance data from both devices was obtained from machine downloads at the end of each treatment arm.
Subjects did not change their exercise regime, diet or medications throughout the duration of the study. At predetermined times patients were fed breakfast, lunch and dinner as well as a snack in the mid-morning and mid-afternoon. The meals were representative of a standard western diet with a total energy of 9433kJ (30.5% fat, 54.6% carbohydrate, 14.9% protein).
Biochemical testing
Biochemical measurements were obtained prior to sleep, upon awakening and 2 h post awakening. All analytes were determined by liquid chromatography and concentrations determined by comparison to corresponding standard curves. Paul to add details.
Statistical Methods
The final analyses included 29 patients who had completed the crossover trial, regardless of compliance with either therapeutic or sham CPAP. Order effect was analysed using unpaired t-tests and main outcomes were analysed using mixed effects models. The treatment, order, time-point and treatment by time-point interaction were included as fixed effects and the patient was a random effect in all models.
Data was analysed with the statistical software package SAS V.9.2 (SAS Institute) and Stata TM version 10 (StataCorp, College Station, TX, USA).
RESULTS
A total of 29 patients completed the trial [24] . Three subjects had incomplete data for part of a visit. Nine participants withdrew or were withdrawn post randomization as previously reported [24] .
Patient demographics, anthropometrics, diagnostic polysomnography data and baseline biochemistry data are as shown in neither was there a correlation between this ratio in CPAP users with AHI, minimum oxygen saturation, oxygen desaturation index (ODI) and arousals (r =0.14, r=0.16, r= 0.18 and r = 0.01 respectively).
There was no effect of compliant (>4 hours) versus non-compliant CPAP use on the A non-randomized study investigating the effect of CPAP on 8-isoprostane measured by exhaled breath analysis showed a beneficial effect [17] . A more recent 12 week randomized controlled trial using 8-isoprostane concentrations in plasma, also showed a reduction in 8-isoprostane levels with CPAP use [16] . The accuracy, reliability and validity of 8-isoprostane measurements particularly when using commercial kits however, have been criticized [26] [27] [28] [29] . Gas chromatography with mass-spectrometry detection, the gold standard, is laborious and costly, prohibiting its use in large epidemiological studies. As a result, enzyme linked immunosorbent assay (ELISA) is often used but is not felt to be comparable to the gold standard.
Conflicting results have been demonstrated in non-randomized CPAP trials measuring MDA/TBARS levels. While some studies have shown a beneficial response to CPAP in patients with moderate to severe OSA after one night and up to 1 year of CPAP use [13, 19, 20] , others have not [30] . Similarly however, measurement of MDA/TBARS has been criticized for its inaccuracy and ambiguity [31] .
Reactive oxygen species are increased by several factors ranging from infection and inflammation to hypoxia related to OSA [32, 33] . The importance of further understanding the mechanistic link between various disease entities including atherosclerosis, and the recurrent OSA related hypoxia has lead to an abundance of basic science and clinical studies. Several antioxidant trials have also been published reflecting the reduced antioxidant capacity in OSA [15, 23, 34] and its partial resolution with CPAP [23] . Improvement in endothelial dysfunction has also been demonstrated in patients with OSA after administration of Vitamin C [35] . The lack of improvement in lipid soluble vitamin E levels in our study is in keeping with previously published data [23] .
There are several potential limitations to our study. Firstly, we did not repeat baseline biochemical testing after the washout period and hence assumed that any positive effect of CPAP on oxidative stress would revert to baseline levels after washout. The length of the washout period was long (4 weeks) however and we could not detect any order effect. Some studies showed a difference after 1-2 nights of CPAP suggesting that reversal of any effect from CPAP may be equally prompt [13, 17] .
Secondly, our sham CPAP compliance was lower than therapeutic CPAP, although the difference was small (1 hour) and it would have been preferable to have longer nightly CPAP with both devices. In addition, our study may not have been adequately powered to detect a difference in lipid based oxidative markers. Lastly, we did not measure non-lipid based oxidative stress markers including reactive nitrogen species mediated oxidative markers eg. nitrotyrosine. We focused on lipid only markers as altered lipid metabolism has been demonstrated in OSA and CPAP has been shown to decrease total cholesterol and triglycerides [24, 36] .
In summary, this is the first randomized sham controlled study investigating the influence CPAP on lipid-based oxidative markers over an 8 week period. No differences in unesterified cholesterol, esterified cholesterol, hydroperoxides and hydroxides and lipid soluble vitamin E levels were observed between the therapeutic and sham CPAP groups. This suggests that CPAP may have a greater influence on non-lipid based oxidative markers.
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